Drug-drug Interaction Study Between UIC202304, and UIC202305
NCT07735052
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Healhty
Interventions
DRUG:
UIC202304 and co-administration of UIC202304 and UIC202305
DRUG:
UIC202305 and co-administration of UIC202304 and UIC202305
Sponsor
Korea United Pharm. Inc.